» Articles » PMID: 33129638

Depression: An Actionable Outcome for Those at Clinical High-risk

Abstract

Comorbid diagnoses are common in youth who are at clinical high-risk (CHR) for developing psychosis, with depression being the most common. The aim of this paper is to examine depression over two years in a large sample of CHR youth who do not make the transition to psychosis, considering both categorical and dimensional ratings of depression severity. The sample consisted of 267 CHR youth who were followed for two years. Based on DSM-IV diagnoses over this time period, 100 CHR individuals never received a diagnosis of depression, 64 individuals continuously met criteria for depression, 92 individuals received a diagnosis of depression at one or more timepoints, and 11 participants had a diagnosis of depression only at 24-months. These groupings were supported by six-monthly ratings on the Calgary Depression Scale. The majority of this sample experienced a major depressive episode on more than one occasion, suggesting that depression and depressive symptoms identify a domain of substantial unmet clinical need. Recommendations are that depression in CHR youth and young adults should be monitored more frequently and that there is a need for clinical trials to address depression systematically in this vulnerable population.

Citing Articles

Psychological and social difficulties in young non-help-seeking adolescents at risk for psychosis: insights from a large cohort study.

Teigset C, Mohn C, Mohn-Haugen C, Laroi F, Rund B Front Psychol. 2024; 15:1430805.

PMID: 39355295 PMC: 11443346. DOI: 10.3389/fpsyg.2024.1430805.


Clinical high risk for psychosis syndrome is associated with reduced neural responding to unpleasant images.

Osborne K, Zhang W, Gupta T, Farrens J, Geiger M, Kraus B J Psychopathol Clin Sci. 2023; 132(8):1060-1071.

PMID: 37796541 PMC: 11812458. DOI: 10.1037/abn0000862.


Factors Associated with Transition to Serious Mental Illness.

Jalali S, Liu L, Wang J, Kennedy S, MacQueen G, Lebel C Can J Psychiatry. 2023; 69(2):79-88.

PMID: 37606525 PMC: 10789229. DOI: 10.1177/07067437231195959.


Ketamine Induces Lasting Antidepressant Effects by Modulating the NMDAR/CaMKII-Mediated Synaptic Plasticity of the Hippocampal Dentate Gyrus in Depressive Stroke Model.

Abdoulaye I, Wu S, Chibaatar E, Yu D, Le K, Cao X Neural Plast. 2021; 2021:6635084.

PMID: 33981335 PMC: 8088363. DOI: 10.1155/2021/6635084.


Commentary. Toward a core outcomes assessment set for clinical high risk.

Woods S, Mourgues-Codern C, Powers 3rd A Schizophr Res. 2020; 227:78-80.

PMID: 32414650 PMC: 8215729. DOI: 10.1016/j.schres.2020.05.008.

References
1.
Addington D, Addington J, Schissel B . A depression rating scale for schizophrenics. Schizophr Res. 1990; 3(4):247-51. DOI: 10.1016/0920-9964(90)90005-r. View

2.
Addington J, Stowkowy J, Liu L, Cadenhead K, Cannon T, Cornblatt B . Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis. Psychol Med. 2018; 49(10):1670-1677. DOI: 10.1017/S0033291718002258. View

3.
Bernard D, Lancon C, Auquier P, Reine G, Addington D . Calgary Depression Scale for Schizophrenia: a study of the validity of a French-language version in a population of schizophrenic patients. Acta Psychiatr Scand. 1998; 97(1):36-41. DOI: 10.1111/j.1600-0447.1998.tb09960.x. View

4.
Allswede D, Addington J, Bearden C, Cadenhead K, Cornblatt B, Mathalon D . Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains. Am J Psychiatry. 2019; 177(2):164-171. PMC: 7002249. DOI: 10.1176/appi.ajp.2019.18111290. View

5.
Addington J, Devoe D, Santesteban-Echarri O . Multidisciplinary Treatment for Individuals at Clinical High Risk of Developing Psychosis. Curr Treat Options Psychiatry. 2019; 6(1):1-16. PMC: 6688178. DOI: 10.1007/s40501-019-0164-6. View